Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design
Follicular helper Tcells (TFH cells), a rare type of immune cell that is essential for inducing a strong and lasting antibody response to viruses and other microbes, have garnered intense interest in recent years but the molecular signals that drive their differentiation had remained unclear. Now, a team of researchers at the La Jolla Institute for Allergy and Immunology has identified a pair of master regulators that control the fate of TFH cells.
Follicular helper T cells (cells with green surface markers) interact closely with B cells (cells with orange surface markers) to facilitate the proliferation of B cells and the production of high affinity antibodies. The interaction site is shown in yellow, DNA in blue.
Credit: Joyce Hu, La Jolla Institute of Allergy and Immunology
Their finding, published in this week's online edition of Nature Immunology, holds great promise for improved vaccine design and may lead to new treatments for immune disorders and possibly even cancer. "Almost all licensed human vaccines work on the basis of inducing a long-term, protective antibody response," says the study's lead author Shane Crotty, Ph.D., a professor in the Institute's Division of Vaccine Discovery. "Being able to enhance or increase the frequency of follicular helper T cells may be an excellent approach for better vaccine design."
Before B cells can launch a full-blown antibody response against invading pathogens they undergo a tightly orchestrated, multi-step maturation process aided by TFH cells. Often compared to a miniaturized Darwinian struggle for survival, this process selectively promotes the proliferation of B cells that produce high-affinity antibodies and weeds out those that produce less potent ones.
"B cells compete for TFH cells to survive," explains postdoctoral researcher and first author Youn Soo Choi, Ph.D., "Only those B cells that produce highly specific antibodies attract TFH cells and are able to proliferate." The survivors undergo successive rounds of mutation and selection resulting in better and better antibodies during the course of an immune response.
"TFH cells are essential for the production of most types of antibodies and defects in TFH function or frequency can have dramatic effects," says Crotty. "It may be particularly important when antibody targets are difficult to recognize and B cells need to explore a bigger mutational landscape. A better understanding of how these cells are produced could really make a difference in how likely it is that your body manages to make good antibodies against an infection."
In an earlier study, Crotty's team had identified the BCL6 gene as a crucial mastermind in the differentiation of TFH cells but important pieces of the puzzles had still been missing. A combination of functional genomics and bioinformatics analysis allowed Choi to narrow the list of potential candidates down to a pair of transcription factors, LEF-1 and TCF-1. Transcription factors act as master switching by binding to regulatory regions in the genome, where they modulate gene activity. He then confirmed the importance of LEF-1 and TCF-1 for the differentiation of TFH cells with the help of mice genetically engineered to lack the genes encoding either LEF-1 or TCF-1.
"Their activity pre-programs CD4+ T cells to respond to TFH induction signals," says Choi. "It seems very likely that any perturbation that results in lower levels of these transcription factors could decrease the likelihood that T cells differentiate into TFH cells."
As a matter of fact, individual differences in the predilection to make more TFH cells could explain why some individuals produce highly efficient antibodies against HIV, while most individuals are unable to mount a potent immune response. "It is very difficult to create high-affinity antibodies for HIV, which are necessary to neutralize virus," explains Crotty. "Interestingly, it turns out that those individuals that are able to make broadly neutralizing antibodies against HIV, have unusually elevated levels of highly functional memory TFH cells. We speculate that these people may have a genetic bias to produce a really good TFH response but we haven't identified it yet."
The research was supported by the La Jolla Institute for Allergy and Immunology, the American Cancer Society (RSG-11-161-01-MPC), and the National Institutes of Health (AI105351, AI112579, AI115149, AI119160, AI113806, AI109976, AI063107 and AI072543).
Full citation: "LEF-1 and TCF-1 orchestrate TFH differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6." Youn Soo Choi, Jodi A Gullicksrud, Shaojun Xing, Zhouhao Zeng, Qiang Shan, Fengyin Li, Paul E Love, Weiqun Peng, Hai-Hui Xue & Shane Crotty. doi:10.1038/ni.3226
ABOUT LA JOLLA INSTITUTE
La Jolla Institute for Allergy and Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading towards its goal: life without disease®.
Gina Kirchweger | EurekAlert!
Transforming plant cells from generalists to specialists
07.12.2016 | Duke University
What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Earth Sciences
07.12.2016 | Earth Sciences
07.12.2016 | Materials Sciences